Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (7) , 445
Abstract
Background: Secondhand smoke (SHS) may be related to worse outcomes in chronic obstructive pulmonary disease (COPD), but the reported SHS prevalence in different studies varied from 27% to 65% and the effects of SHS are still questionable among these patients. The study aims were to estimate the objective SHS prevalence and explore the SHS impact on outcomes among COPD patients without active smoking. Methods: A cross-sectional design combined with longitudinal death outcome. We selected COPD patients over 40 years old based on the spirometry from National Health and Nutrition Examination Survey (2007–2012), and used the tobacco-specific biomarkers [cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol] to determine exposure statuses (active smoking, SHS exposure, or no smoke exposure). Then we estimated the short-term (past 2–4 days) and medium-term (past 6–12 weeks) SHS prevalence among 334 patients without active smoking. Weighted multiple regressions were performed to assess the associations between medium-term SHS exposure and outcomes (symptoms, health status, medical institution visits, and death). Results: Among the patients without active smoking, the objective prevalence rates of short-term and medium-term SHS were 66.65% [95% confidence interval (CI), 59.63–73.67%] and 34.91% (95% CI, 28.86%–40.96%), respectively. Medium-term SHS exposure showed a significant effect (odds ratio, 3.57; 95% CI, 1.22–10.40) on more chronic coughing after adjusting for the covariates and indicated a trend of unadjusted increasing death risk (log-rank test, P=0.01). Conclusions: Among COPD patients without active smoking, both short-term and medium-term SHS exposure are prevalent. Chronic cough may be the most susceptible patient-centred outcome related to medium-term SHS exposure. The crude longitudinal trend of elevated death risk associated with medium-term SHS exposure deserves further study.Keywords
This publication has 39 references indexed in Scilit:
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Impact of current cough on health-related quality of life in patients with COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2016
- Vital Signs: Disparities in Nonsmokers’ Exposure to Secondhand Smoke — United States, 1999–20122015
- Obesity as a susceptibility factor to indoor particulate matter health effects in COPDEuropean Respiratory Journal, 2015
- Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010Respiratory Research, 2013
- Sub-chronic exposure to second hand smoke induces airspace leukocyte infiltration and decreased lung elastanceFrontiers in Physiology, 2012
- Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokersCarcinogenesis, 2011
- Risk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax, 2003
- Metabolism of nicotine to cotinine studied by a dual stable isotope methodClinical Pharmacology & Therapeutics, 1994
- Deaths from all causes in non-smokers who lived with smokers.American Journal of Public Health, 1989